Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
"If approved, retatrutide will be the first in a new class of medications." Eli Lilly announced results from its phase 3 trial TRIUMPH-4 in December, testing retatrutides effect on weight loss and other health conditions
Melasma that is resistant to hydroquinone is known to benefit from it
Who Should Not Take It
At-home kits are pricier but less accurate
KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs Findings Key Findings The latest KFF Health Tracking Poll finds that about one in eight adults (12%) say they have ever taken a GLP-1 agonist an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes for adults with heart disease including 6% who say they are currently taking such a drug
At the highest dose (12 mg weekly), mean body weight reduction reached 24.2%, compared with a 2.1% reduction in the placebo arm
US$ 26.77
US$ 26.50
US$ 27.93
US$ 22.98
US$ 26.44
US$ 21.66
US$ 23.68
US$ 24.44
US$ 28.30
US$ 24.68
